Browsing Tag
Ligand Pharmaceuticals
3 posts
Ovid Therapeutics (NASDAQ: OVID) surges 28% on $175m private placement: What does it mean for biotech investors?
Ovid Therapeutics (NASDAQ: OVID) jumped 28% after securing $175M via a PIPE deal. Explore its pipeline focus, stock sentiment, and investor outlook.
Primrose Bio emerges as biotech powerhouse, secures $15m from Ligand Pharmaceuticals
Primrose Bio, Inc. has been founded as a merger between Primordial Genetics, Inc. and Pelican Technology Holdings, Inc…
Ligand Pharmaceuticals to acquire protein therapeutics developer Pfenex
US biopharma company Ligand Pharmaceuticals has signed a deal worth up to $516 million to acquire Pfenex, a…